Anticonvulsant effect of neural regeneration peptide 2945 on pentylenetetrazol-induced seizures in rats. (February 2015)

• Record Type: Journal Article
• Authors: Sajadian, Azadeh; Esteghamat, Sana; Karimzadeh, Fariba; Eshaghabadi, Arezou; Sieg, Frank; Speckmann, Erwin-Josef; Meuth, Sven; Seidenbecher, Thomas; Budde, Thomas; Gorji, Ali
• Is Part Of: Neuropeptides. Volume 49(2015)
• Page Start: 15
• Page End: 23
• Publication Date: 2015-02
• Subjects: DAB 3-3′-diaminobenzidine -- NRPs neuron regeneration peptides -- OTCs organotypic tissue cultures -- PFA paraformaldehyde -- PTZ pentylenetetrazol -- PBS phosphate buffered saline; Neuroinflammation -- Epilepsy -- Neuropharmacology -- Brain -- In vivo; Neuropeptides -- Periodicals; Neuropeptides; Neuropeptides -- Périodiques; Neuropeptides; Electronic journals; Periodicals; 572.65
• DOI: 10.1016/j.npep.2014.11.002
• Languages: English
• ISSNs: 0143-4179

Abstract

Highlights: The effect of neuron regeneration peptide 2945 (NRP) on PTZ-induced seizures was tested. NRP inhibited PTZ-induced seizure attacks and production of dark neurons. NRP enhanced the expression of GABAA receptor and GAD-65 in the hippocampus. This study points to the potential of NRP as an antiepileptic drug. Abstract: Neuron regeneration peptides (NRPs) are small synthetic peptides that stimulate neural proliferation, migration, and differentiation with no apparent toxicity and high target specificity in CNS. The aim of this study was to investigate the effect of NRP2945 on seizure activity induced by pentylenetetrazol (PTZ) in rats. Using behavioural assessment and electrocorticographical recordings, the effects of different doses of NRP2945 (5–20 µg/kg) were tested on seizure attacks induced by PTZ injection. In addition, the effect of NRP2945 was evaluated on the production of dark neurons and expression of GABAA receptor α and β subunits and GAD-65 in the hippocampus and somatosensory cortex of the rat brain. Intraperitoneal injection of NRP2945 at 20 µg/kg prevented seizure attacks after PTZ injection. NRP2945 at doses of 5 and 10 µg/kg significantly decreased the total duration of seizure attacks and reduced the amplitude, duration and latency of epileptiform burst discharges induced by PTZ. In addition, the peptide significantly inhibited the production of dark neurons in the hippocampus and somatosensory cortex of epileptic rats. NRP2945 also significantly increased the expression of GABAA receptor α and β subunits and GAD-65 in the hippocampus and somatosensory cortex compared with PTZ treated rats. This study indicates that NRP2945 is able to prevent the seizure attacks and neuronal injuries induced by PTZ, likely by stimulating GABAA and GAD-65 protein expression and/or protecting these components of GABAergic signalling from PTZ-induced alteration. Further studies are needed to elucidate the potential role of NRP2945 as an antiepileptic drug.